Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

Our writer takes a look at three red-hot growth stocks that have more than doubled this year to see if any of them interest him. The post 3 growth stocks that have rocketed more than 100% in 2025!